Neo-Adjuvant Chemotherapy in Gastric Adenocarcinoma: Impact on Surgical and Oncological Outcomes in a Western Referral Center.

Although the difference did not reach statistical significance, a trend toward a higher proportion of advanced T-stage tumors was observed in the NACT group (82–74.5% vs. 89–61.8% T3–4 stage; p = 0.07). 3.2.

also in 111,027 other papers